Driving Healthcare Solutions Through Expertise & Collaboration
Premier CDMO Partner for Pharmaceutical Innovation
Indo Healthcare Formulations Pvt Ltd (IHFPL) delivers end-to-end contract development and manufacturing services with DCGI-approved excellence across tablets, capsules, ointments, and sachets.
Your Strategic
Pharmaceutical Partner
IHFPL stands as a leading Contract Development and Manufacturing Organization (CDMO) committed to technology transfer, loan licensing, novel drug delivery systems (NDDS), and first-time launches in India. With 350+ formulations spanning 20+ therapeutic categories, we provide customized manufacturing and packaging solutions for global pharmaceutical partners, ensuring regulatory compliance and market readiness.
- Comprehensive CDMO capabilities from development to commercialization
- DCGI approvals for innovative first-time product launches
- Advanced formulations including SR/ER, bilayered tablets, and dispersibles
- Flexible packaging solutions tailored to client specifications
From Specialized CDMO to Industry Leader
Building Excellence in Pharmaceutical Manufacturing
IHFPL has evolved from a focused contract manufacturer to a comprehensive CDMO offering technology transfer, loan licensing, and strategic partnerships. Our journey reflects consistent expansion across therapeutic categories, advanced formulations, and regulatory achievements, now serving global partners with 350+ proven formulations.
From Specialized CDMO to Industry Leader
Specialized CDMO Capabilities
IHFPL combines technical manufacturing prowess with regulatory expertise to deliver seamless solutions from technology transfer to market-ready products.
Technology Transfer
Expert process scale-up with DCGI-approved protocols for efficient commercialization.
Contract Manufacturing
350+ formulations across tablets, capsules, ointments, and sachets in 20+ categories.
Loan Licensing
Flexible licensing arrangements enabling rapid market entry and distribution.
Novel Drug Delivery
NDDS innovations, including SR/ER formulations, bilayered tablets, and dispersibles.
Custom Packaging
Client-specific solutions with Alu-Alu, Blister, and Strip configurations.
Technical Partnerships
Strategic collaborations and joint ventures for innovative product launches.
From Specialized CDMO to Industry Leader
What Sets IHFPL Apart
Our unique combination of regulatory expertise, technical capabilities, and client-centric approach positions us as the preferred CDMO partner.
- DCGI-Approved Innovation: First-time launches with regulatory excellence
- Comprehensive Dosage Forms: Tablets, capsules, ointments, sachets coverage
- Advanced Formulations: Bilayered, SR/ER, dispersible technologies
- Flexible Customization: Packaging and manufacturing per client specs
- 20+ Therapeutic Expertise: Complete healthcare category coverage
- End-to-End CDMO: From tech transfer to market delivery
Transforming Pharmaceutical Manufacturing
- Market Access Acceleration: Enabling first-time launches through DCGI approvals
- Innovation Leadership: Pioneering NDDS and advanced formulations
- Global Partnership Enablement: Technology transfer for international scale-up
- Customized Solutions: 350+ formulations tailored to diverse therapeutic needs
- Regulatory Confidence: cGMP-compliant processes meeting global standards
Partner with Proven Excellence
IHFPL combines manufacturing expertise, regulatory compliance, and innovation to deliver results that matter for your pharmaceutical success.
Regulatory Mastery
DCGI approvals ensure compliance and market confidence
Technical Innovation
Advanced NDDS, bilayered, and controlled-release formulations
Manufacturing Scale
350+ formulations across tablets, capsules, ointments, sachets
Client Flexibility
Custom packaging and client-specific manufacturing solutions
